These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 197445)

  • 1. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
    Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
    Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotides in mental disorder.
    Belmaker RH; Zohar J; Ebstein RP
    Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP in the CSF of patients with schizophrenia.
    Biederman J; Rimon R; Ebstein R; Belmaker RH; Davidson JT
    Br J Psychiatry; 1977 Jan; 130():64-7. PubMed ID: 188506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH; Dasberg H; Ebstein RP
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Geisler A; Bech P; Johannesen M; Rafaelsen OJ
    Neuropsychobiology; 1976; 2(4):211-20. PubMed ID: 189250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin, dopamine and schizophrenia.
    Garver DL; Beinfeld MC; Yao JK
    Psychopharmacol Bull; 1990; 26(3):377-80. PubMed ID: 2274639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
    Belmaker RH; Ebstein RP; Biederman J; Stern R; Berman M; van Praag HM
    Psychopharmacology (Berl); 1978 Jul; 58(3):307-10. PubMed ID: 210480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.
    Brackenridge CJ; Jones IH
    J Neurol Neurosurg Psychiatry; 1968 Aug; 31(4):326-9. PubMed ID: 5684392
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic AMP and GMP in the cerebrospinal fluid after high-dose haloperidol treatment.
    Belmaker RH; Zohar J; Rimon R; Averbuch I
    Pol J Pharmacol Pharm; 1984; 36(2-3):217-20. PubMed ID: 6089157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid zinc concentrations in ex-heroin addicts and patients with schizophrenia: some preliminary observations.
    Potkin SG; Shore D; Torrey EF; Weinberger DR; Gillin JC; Henkin RI; Agarwal RP; Wyatt RJ
    Biol Psychiatry; 1982 Nov; 17(11):1315-22. PubMed ID: 6129905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expectation of outcome from maintenance therapy in chronic schizophrenic patients.
    Johnson DA
    Br J Psychiatry; 1976 Mar; 128():246-50. PubMed ID: 3251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood serum tryptophan in schizophrenic patients and the dependence of its level on treatment with neuroleptics].
    Szafranek J
    Ann Acad Med Stetin; 1970; 16():519-34. PubMed ID: 5525985
    [No Abstract]   [Full Text] [Related]  

  • 18. [Excitability of the vestibular system in schizophrenic patients treated with neuroleptics].
    Szymczewska J
    Ann Acad Med Stetin; 1971; 17():429-50. PubMed ID: 5317128
    [No Abstract]   [Full Text] [Related]  

  • 19. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
    Lydecken K
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(1):75-82. PubMed ID: 323966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the efficacy of oxypertine in acute and choronic schizophrenic patients.
    Muniz AF; Terra SO; Bueno JR; Vianna Filho U
    J Bras Psiquiatr; 1968; 17(1):83-95. PubMed ID: 5760628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.